Cytogenetic abnormalities in multiple myeloma: poor prognosis linked to concomitant detection in random and focal lesion bone marrow samples and associated with high-risk gene expression profile

Yiming Zhou, Bijay Nair, John D. Shaughnessy, Marie Astrid Cartron, Jeff Haessler, Elias Anaissie, Frits Van Rhee, John Crowley, Bart Barlogie

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

The clinical significance of cytogenetic abnormalities (CA) present in randomly sampled (RS) or focal lesion (FL) bone marrow sites was examined in 419 untreated myeloma patients. Among 290 patients with gene expression profiling (GEP) data generated from RS sites, GEP-defined high-risk was present in 52% of the RS+/FL+ group but in only 9% of the remainder (P < 0·001). The RS+/FL+ constellation (18%) was an independent predictor of poor survival, also after adjusting for GEP-derived risk and TP53 status (Hazard ratio = 2·42, P = 0·004). The prevalence of high-risk myeloma in the RS+/FL+ group may reflect a dissemination-prone condition not shared by the other three groups.

Original languageEnglish
Pages (from-to)637-641
Number of pages5
JournalBritish Journal of Haematology
Volume145
Issue number5
DOIs
StatePublished - Jun 2009
Externally publishedYes

Keywords

  • Cytogenetics
  • Focal lesions
  • Gene array
  • Myeloma
  • Prognosis

Fingerprint

Dive into the research topics of 'Cytogenetic abnormalities in multiple myeloma: poor prognosis linked to concomitant detection in random and focal lesion bone marrow samples and associated with high-risk gene expression profile'. Together they form a unique fingerprint.

Cite this